Laurence Jay Korn, Director at PDL BIOPHARMA, INC. (PDLI), sold 15,000 shares at $31.80 ($477K) on 2006-03-03, disclosed to the SEC on 2006-03-07.
Scheduled sale ($477k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.80 | 13,800 | $439K | 92.0% |
| 2 | $31.82 | 1,200 | $38K | 8.0% |
| Total | $31.80 avg | 15,000 | $477K | 100% |
| Filing → |
| PDLI | SELL | 2006-03-03 | $789K | — | Filing → |
| PDLI | SELL | 2006-03-02 | $6K | — | Filing → |
| PDLI | SELL | 2006-01-11 | $2.2M | — | Filing → |